Our Alumni, Frequency Therapeutics, Announces $32 Million Series A Investment. Congratulations!

Congratulations to our alumni, Frequency Therapeutics team with this great achievement! The funding of $32 million Series A will support their clinical development and research for hearing restoration therapeutic. We wish you all the best in your future endeavors. Frequency Therapeutics,a company developing a pipeline of new drugs that activate progenitor cells within the body, today announced the closing of a $32 million Series A financing. The funding round was led by CoBro Ventures. Additional participating investors included Morningside Ventures, Emigrant Capital Corp., Korean Investment Partnership, Alexandria Real Estate Equities and other U.S. and international investors. Read more he

6th Annual Advances in Chemical Sciences Symposium

It was an honor for CreaGen Life Science Incubator and CreaGen Inc. to have served as volunteers at the “6th Annual Advances in Chemical Sciences Symposium” to support the community of the New Eastern Section of the Amercian Chemistry Society (NESACS). The speakers have shared their latest break-throughs and new discoveries in the chemistry realm. Attendees and vendors from all around New England area and Canada came together to be a part of incredible event and made it such a great success. We look to the next ACS Symposium. May 5th Symposium: “6th Annual Advances in Chemical Sciences Symposium” at Royal Sonesta Speakers: Sabine Hadida: Vertex Pharmaceuticals, San Diego, CA Title: Discovery

Featured Posts
Recent Posts
Archive
Search By Tags

© 2019 by CreaGen Inc. 

299 Washington St

Woburn, MA 01801 

Tel: 781.938.1122

Fax: 781.938.1123

 

info@creagenbio.com

  • Grey LinkedIn Icon
  • Grey Twitter Icon
  • Grey YouTube Icon
  • Grey Facebook Icon

Business Accelerator | CreaGen C2I | Life Science | Lease Lab Space | Biotech